Remdesivir

The US Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19…

Jubilant Life Sciences Ltd on Monday announced that its subsidiary, Jubilant Generics,has launched remdesivir for injection, under the brand name 'JUBI-R', in the Indian market at a price of Rs 4,700 per vial of 100 mg.The company said it…

The European Commission said that it has signed a 63 million-euro contract with American pharmaceutical company Gilead to secure doses of Veklury, the brand name for Remdesivir, for the treatment of COVID-19.The Commission said in a…